HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients

PURPOSE: This study aimed to evaluate the clinical value of high-intensity focused ultrasound (HIFU) combined with gemcitabine (GEM) in treating unresectable pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND METHODS: A total of 523 unresectable PDAC patients were recruited from December 30, 2007...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Zhouyu, Xie, Jing, Chen, Qiwen, Zhang, Chenyue, Xu, Litao, Song, Libin, Meng, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362964/
https://www.ncbi.nlm.nih.gov/pubmed/30774386
http://dx.doi.org/10.2147/OTT.S185424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362964/
https://www.ncbi.nlm.nih.gov/pubmed/30774386
http://dx.doi.org/10.2147/OTT.S185424

Ejemplares similares